Management Team

Lung Cancer

Overview

Lung cancer develops when abnormal cells in the lungs grow and multiply uncontrollably, forming a tumour. Over time, this tumour may spread (metastasise) to other parts of the body.

  • Non-small cell lung cancer (NSCLC)
  • Small cell lung cancer (SCLC)
  • Lung carcinoid tumour

  • Smoking (leading cause)
  • Passive exposure to second-hand smoke
  • Occupational exposure to harmful substances like fumes, soot, and arsenic
  • Exposure to asbestos
  • Pre-existing lung conditions like fibrosis and emphysema

  • Persistent coughing or wheezing
  • Chest pain or discomfort
  • Shortness of breath or extreme fatigue
  • Coughing up blood or rusty-coloured sputum
  • Recurrent respiratory infections

  • Imaging tests: CT, PET, or MRI scans, particularly of the brain in advanced cases
  • Biopsy: CT guided or EBUS (Endobronchial Ultrasound) biopsy
  • Nodal staging: Mediastinoscopy or EBUS for lymph node evaluation
  • Sputum cytology: Microscopic analysis of sputum samples
  • Pulmonary function tests: To assess lung capacity and function for operable cases
  • Cardiac evaluation: To ensure surgical readiness for operable lung cancers

  • Surgery: Performed using conventional technique, VATS, or robotic methods
  • Chemotherapy
  • Radiation therapy
  • Targeted therapy Designed for specific genetic mutations in cancer cells
  • Immunotherapy: Boosts the immune system to fight cancer

The treatment options depend on the cancer stage and medical condition of the patient. Either one or different combinations of the above therapies may be used for the individual.

  • Quit smoking
  • Avoid exposure to second-hand smoke
  • Smokers may consider low-dose CT scans for early detection after consulting a physician
  • Maintain a healthy diet with regular exercise

Prognosis varies significantly based on the stage of cancer at diagnosis, the patient’s overall health, and the response to treatment.

Bottom to top